Aspirin 250mg Tablet Franchise in Ahmedabad

Antiplatelet & Analgesic Tablet Supplier in Bangalore

Aspirin 250mg Medicine Distributor in Hyderabad

Pain Relief & Heart Health Tablet Franchise in Jaipur

Cardiovascular & Analgesic Tablet Stockist in Mumbai
Aspirin Tablet Export & Manufacturing in Chandigarh

Home/Products /aspirin-250mg-tablet

Asprole 250 Tablet

Composition : Aspirin (250mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Aspofoli 250 Tablet contains Aspirin 250mg, a dual-purpose formulation used for antiplatelet therapy and pain management. It helps prevent blood clot formation, reducing the risk of heart attack and stroke, while also offering effective relief from mild to moderate pain, fever, or inflammation.

The 250mg strength provides an optimal balance for cardiovascular support and analgesic effect. It is frequently prescribed for patients requiring stronger antiplatelet coverage or those needing short-term relief from musculoskeletal or headache pain. Its reliable formulation ensures consistent therapeutic outcomes, making it a preferred choice among healthcare practitioners.

For distributors and suppliers, Aspofoli 250 Tablet is a fast-moving, essential medicine. Its regular prescription for both cardiovascular care and pain relief ensures sustained demand across pharmacies, clinics, hospitals, and healthcare centers. Seasonal spikes in cardiac care and pain management contribute to high turnover and repeat orders.

Adding Aspofoli 250 Tablet to your portfolio strengthens your cardiovascular and analgesic segment, opening business opportunities for bulk supply, institutional orders, export, and third-party manufacturing. Its high clinical value, versatile application, and constant market requirement make it a profitable and strategic addition for any pharma distributor or stockist.

Read More

About the Product

Aspofoli 250 Tablet contains Aspirin 250mg, a dual-purpose formulation used for antiplatelet therapy and pain management. It helps prevent blood clot formation, reducing the risk of heart attack and stroke, while also offering effective relief from mild to moderate pain, fever, or inflammation.

The 250mg strength provides an optimal balance for cardiovascular support and analgesic effect. It is frequently prescribed for patients requiring stronger antiplatelet coverage or those needing short-term relief from musculoskeletal or headache pain. Its reliable formulation ensures consistent therapeutic outcomes, making it a preferred choice among healthcare practitioners.

For distributors and suppliers, Aspofoli 250 Tablet is a fast-moving, essential medicine. Its regular prescription for both cardiovascular care and pain relief ensures sustained demand across pharmacies, clinics, hospitals, and healthcare centers. Seasonal spikes in cardiac care and pain management contribute to high turnover and repeat orders.

Adding Aspofoli 250 Tablet to your portfolio strengthens your cardiovascular and analgesic segment, opening business opportunities for bulk supply, institutional orders, export, and third-party manufacturing. Its high clinical value, versatile application, and constant market requirement make it a profitable and strategic addition for any pharma distributor or stockist.

Some patients may experience stomach discomfort, nausea, acidity, mild bleeding tendencies such as gum or nosebleeds. Rarely, severe gastrointestinal bleeding, allergic reactions, or tinnitus may occur.

It is indicated for the prevention of heart attack, stroke, and transient ischemic attacks (TIAs), as well as for managing mild to moderate pain, fever, or inflammation. It supports patients with coronary artery disease and those at risk of cardiovascular events.

Use only under medical supervision. Avoid in patients with active ulcers, bleeding disorders, aspirin allergy, or severe liver/kidney disease. Do not take with other blood thinners without medical advice. Not recommended for children due to the risk of Reye’s syndrome.

Store in a cool, dry place below 25°C, protected from moisture and sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation